Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Cited In for PubMed (Select 8725145)

1.

Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine model.

Silva M, da Costa Guerra JF, Sampaio AF, de Lima WG, Silva ME, Pedrosa ML.

Biomed Res Int. 2015;2015:272617. doi: 10.1155/2015/272617. Epub 2015 Jan 18.

2.

Signalling mechanisms regulating phenotypic changes in breast cancer cells.

Volinsky N, McCarthy CJ, von Kriegsheim A, Saban N, Okada-Hatakeyama M, Kolch W, Kholodenko BN.

Biosci Rep. 2015 Mar 18;35(2). pii: e00178. doi: 10.1042/BSR20140172.

3.

ABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesity.

Liu X, Liu J, Liang S, Schlüter A, Fourcade S, Aslibekyan S, Pujol A, Graf GA.

Mol Pharmacol. 2014 Nov;86(5):505-13. doi: 10.1124/mol.114.092742. Epub 2014 Aug 14.

PMID:
25123288
4.

Therapeutic approaches to drug targets in atherosclerosis.

Jamkhande PG, Chandak PG, Dhawale SC, Barde SR, Tidke PS, Sakhare RS.

Saudi Pharm J. 2014 Jul;22(3):179-90. doi: 10.1016/j.jsps.2013.04.005. Epub 2013 Nov 5. Review.

6.

Effects of interventions on adiponectin and adiponectin receptors.

Lee S, Kwak HB.

J Exerc Rehabil. 2014 Apr 30;10(2):60-8. doi: 10.12965/jer.140104. eCollection 2014 Apr. Review.

7.

Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.

McIntosh AL, Huang H, Storey SM, Landrock KK, Landrock D, Petrescu AD, Gupta S, Atshaves BP, Kier AB, Schroeder F.

Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15;307(2):G164-76. doi: 10.1152/ajpgi.00369.2013. Epub 2014 May 29.

PMID:
24875102
8.

Dyslipidemia in patients with chronic and end-stage kidney disease.

Omran J, Al-Dadah A, Dellsperger KC.

Cardiorenal Med. 2013 Oct;3(3):165-77. doi: 10.1159/000351985. Epub 2013 Jul 13. Review.

9.

The effect of acyclic retinoid on the metabolomic profiles of hepatocytes and hepatocellular carcinoma cells.

Qin XY, Wei F, Tanokura M, Ishibashi N, Shimizu M, Moriwaki H, Kojima S.

PLoS One. 2013 Dec 23;8(12):e82860. doi: 10.1371/journal.pone.0082860. eCollection 2013.

10.
11.

DHA attenuates postprandial hyperlipidemia via activating PPARα in intestinal epithelial cells.

Kimura R, Takahashi N, Lin S, Goto T, Murota K, Nakata R, Inoue H, Kawada T.

J Lipid Res. 2013 Dec;54(12):3258-68. doi: 10.1194/jlr.M034942. Epub 2013 Oct 16.

12.

Association between APOE, SCARB1, PPARα polymorphisms and serum lipids in a population of Lithuanian adults.

Smalinskiene A, Petkeviciene J, Luksiene D, Jureniene K, Klumbiene J, Lesauskaite V.

Lipids Health Dis. 2013 Aug 6;12:120. doi: 10.1186/1476-511X-12-120.

13.

Molecular docking of Glyceroneogenesis pathway intermediates with Peroxisome Proliferator- Activated Receptor-Alpha (PPAR-α).

Subramani PA, Panati K, Narala VR.

Bioinformation. 2013 Jul 12;9(12):629-32. doi: 10.6026/97320630009629. Print 2013.

14.

PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

Contreras AV, Torres N, Tovar AR.

Adv Nutr. 2013 Jul 1;4(4):439-52. doi: 10.3945/an.113.003798. Review.

15.

Fish oil and the pan-PPAR agonist tetradecylthioacetic acid affect the amino acid and carnitine metabolism in rats.

Bjørndal B, Brattelid T, Strand E, Vigerust NF, Svingen GF, Svardal A, Nygård O, Berge RK.

PLoS One. 2013 Jun 24;8(6):e66926. doi: 10.1371/journal.pone.0066926. Print 2013.

16.

Inhibitory Effects of Hwangryunhaedok-Tang in 3T3-L1 Adipogenesis by Regulation of Raf/MEK1/ERK1/2 Pathway and PDK1/Akt Phosphorylation.

Kwak DH, Lee JH, Kim DG, Kim T, Lee KJ, Ma JY.

Evid Based Complement Alternat Med. 2013;2013:413906. doi: 10.1155/2013/413906. Epub 2013 May 23.

17.

High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.

Petrescu AD, McIntosh AL, Storey SM, Huang H, Martin GG, Landrock D, Kier AB, Schroeder F.

Biochim Biophys Acta. 2013 Aug;1831(8):1412-25. doi: 10.1016/j.bbalip.2013.05.008. Epub 2013 Jun 6.

18.

Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men.

Berge K, Piscitelli F, Hoem N, Silvestri C, Meyer I, Banni S, Di Marzo V.

Lipids Health Dis. 2013 May 27;12:78. doi: 10.1186/1476-511X-12-78.

19.

Pharmacological approaches to restore mitochondrial function.

Andreux PA, Houtkooper RH, Auwerx J.

Nat Rev Drug Discov. 2013 Jun;12(6):465-83. doi: 10.1038/nrd4023. Epub 2013 May 13. Review.

20.

Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.

Schmilovitz-Weiss H, Hochhauser E, Cohen M, Chepurko Y, Yitzhaki S, Grossman E, Leibowitz A, Ackerman Z, Ben-Ari Z.

Lipids Health Dis. 2013 Mar 25;12:41. doi: 10.1186/1476-511X-12-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk